HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$2.01
Day range
$1.92 - $2.00
Year range
$1.04 - $3.73
Market cap
294.45M USD
Avg Volume
1.76M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 38.90M | 12.21% |
Operating expense | 25.01M | -5.31% |
Net income | 2.64M | 183.39% |
Net profit margin | — | — |
Earnings per share | 0.01 | 150.00% |
EBITDA | 3.70M | 190.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.68M | -29.14% |
Total assets | 235.75M | 8.20% |
Total liabilities | 264.20M | 4.99% |
Total equity | -28.45M | — |
Shares outstanding | 152.56M | — |
Price to book | -10.58 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.64M | 183.39% |
Cash from operations | -8.87M | 6.79% |
Cash from investing | 2.27M | 77.86% |
Cash from financing | 64.00K | 481.82% |
Net change in cash | -6.53M | 20.59% |
Free cash flow | -10.39M | -2.68% |
About
Founded
1983
Headquarters
Website
Employees
122
